GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » 1-Year ROIIC %

Clearmind Medicine (Clearmind Medicine) 1-Year ROIIC % : 12.25% (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Clearmind Medicine's 1-Year ROIIC % for the quarter that ended in Jan. 2024 was 12.25%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Clearmind Medicine's 1-Year ROIIC % or its related term are showing as below:

CMND's 1-Year ROIIC % is ranked better than
59.86% of 1460 companies
in the Biotechnology industry
Industry Median: -4.24 vs CMND: 12.25

Clearmind Medicine 1-Year ROIIC % Historical Data

The historical data trend for Clearmind Medicine's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine 1-Year ROIIC % Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
1-Year ROIIC %
Get a 7-Day Free Trial 1,950.00 -3,133.33 -3,450.00 -858.34 3.46

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -916.37 42.38 107.07 3.46 12.25

Competitive Comparison of Clearmind Medicine's 1-Year ROIIC %

For the Biotechnology subindustry, Clearmind Medicine's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's 1-Year ROIIC % falls into.



Clearmind Medicine 1-Year ROIIC % Calculation

Clearmind Medicine's 1-Year ROIIC % for the quarter that ended in Jan. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -4.761 (Jan. 2024) - -5.2695 (Jan. 2023) )/( 4.52 (Jan. 2024) - 0.368 (Jan. 2023) )
=0.5085/4.152
=12.25%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Clearmind Medicine  (NAS:CMND) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Clearmind Medicine 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.